查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1930057

全球下一代定序市场：市场规模、占有率、成长率、产业分析、按类型、应用和地区划分的分析以及未来预测（2025-2034）

Next-Generation Sequencing Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2025-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 202 Pages | 商品交期: 请询问到货日

价格

次世代定序 (NGS) 市场成长驱动因子

预计全球次世代定序 (NGS) 市场规模在 2025 年将达到 104.4 亿美元，并在 2026 年达到 117.9 亿美元。预计到 2034 年将进一步成长至 383.4 亿美元，预测期内复合年增长率 (CAGR) 为 15.88%。北美地区在 2025 年将以 56.01% 的市占率领先，这主要得益于先进的研究基础设施、大量的研发投资、在临床和研究领域积极采用基因组学技术，以及 Illumina、Thermo Fisher Scientific 和 PacBio 等主要厂商的存在。

次世代定序 (NGS) 是一项革命性的技术，能够实现高通量、可扩展且快速的 DNA 定序，从而变革基因组研究和临床诊断。其应用涵盖基因检测、非侵入性产前检测、肿瘤学、传染病监测和个人化医疗等领域。 COVID-19 疫情加速了 NGS 的普及，其在 SARS-CoV-2 病毒的研究、监测和测序中的应用，刺激了疫苗研发的研究活动和投资。

主要市场驱动因子

诊断和研究领域的多元化应用：NGS 成本的下降和准确性的提高，正在拓展其在诊断领域的应用，包括癌症筛检、生殖医学、遗传疾病检测和伴随诊断。例如，赛默飞世尔科技和拜耳于 2024 年 3 月合作开发基于 NGS 的伴随诊断检测方法，以支援临床研发。

技术进步与产品创新：仪器和耗材的持续创新正在提升定序速度、准确性和数据分析能力。 2022年6月，PerkinElmer推出了BioQule NGS系统，这是一款自动化桌上型解决方案；2023年3月，Illumina推出了Connected Insights，这是一款基于云端的临床NGS资料分析软体。这些进步正在促进NGS技术在研究和临床应用中的可近性、效率和普及性。

政府主导的计画与基因组计画：诸如印度基因组计画、法国个人化医疗计画和沙乌地阿拉伯人类基因组计画等大型基因组计画正在加速NGS技术的广泛应用。世界各国政府都在资助基因组学研究和开发，以加强疾病诊断、个人化医疗和生物技术发展。

市场限制因子

NGS市场面临诸多挑战，包括发展中国家熟练人员短缺、高额投资需求以及由于定序资料量庞大而导致的资料储存限制。此外，新兴地区缺乏充分利用NGS技术的基础设施，限制了其应用。

市场区隔

依类型划分：市场分为产品与服务两大类。 2026年，产品类（包括仪器和耗材）将占市场主导地位，市占率高达86.10%。这主要得益于产品的高使用率、持续的新产品发布以及良好的供应。由于外包业务的增加，包括定序即服务在内的服务预计将稳定成长。

依技术划分：定序技术包括合成定序（SBS）、奈米孔定序和离子半导体定序。在 Illumina 强大的产品组合的推动下，预计到 2026 年，SBS 将占 68.41% 的市场占有率。奈米孔测序因其便携性和长读长能力，预计将快速增长。

依应用领域划分：市场分为临床应用与研究应用两大类。到 2026 年，临床应用将占 51.96% 的市场占有率，主要驱动因素包括肿瘤学、心血管疾病、遗传疾病诊断和生殖医学。研究应用预计将因大型专案和技术应用而成长。

按最终用户划分：到 2026 年，製药和生物技术公司将占 48.00% 的市场占有率，主要驱动因素包括研究合作、药物发现以及在研发流程中采用 NGS 技术。由于政府研究资助和基因组计划，学术和研究机构也在扩大其应用范围。

区域市场分析

预计北美市场规模在2025年将达到58.5亿美元，并在2026年达到61.8亿美元。强大的研发资金和先进的基础设施将使其保持领先地位。亚太地区预计将呈现最高的复合年增长率，这主要得益于印度基因组计划等举措以及中国和日本基因组医学的快速发展。欧洲受益于强大的医疗基础设施和政府对基因组研究的支持。拉丁美洲以及中东和非洲预计将实现温和成长，这得益于合作伙伴关係以及基因组学领域能力的不断提升。

目录

第一章：引言

第二章：摘要整理

第三章：市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机遇
  • 市场趋势

第四章：关键考虑因素

  • 主要国家/地区主要疾病盛行率（2025 年）
  • 主要国家/地区监管和报销状况概述
  • 主要公司新产品发布
  • 主要公司主要产业趋势
  • 次世代定序技术进展概述
  • COVID-19 的影响市场

第五章 全球次世代定序市场分析：洞察与预测（2021-2034）

  • 市场分析、洞察与预测：依类型划分
    • 依产品划分
      • 设备
      • 耗材
    • 服务
  • 市场分析、洞察与预测：依技术划分
    • 合成定序 (SBS)
    • 奈米孔定序
    • 离子半导体定序
    • 其他
  • 市场分析、洞察与预测：依应用划分
    • 研究与应用
    • 临床
      • 心血管
      • 肿瘤
      • 遗传疾病
      • 生殖医药
  • 市场分析、洞察与预测：依最终用户划分
    • 製药与生技公司
    • 学术与研究机构
    • 其他
  • 市场分析、洞察与预测：按地区划分
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第六章 北美次世代定序市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 美国
    • 加拿大

第七章 欧洲次世代定序市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 斯堪的纳维亚
    • 欧洲其他地区

第八章 亚太地区次世代定序市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 东南亚
    • 亚太其他地区

第九章 拉丁美洲次世代定序市场分析：洞察与预测（2021-2034）

  • 依国家/地区
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区

第十章 中东与非洲次世代定序市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 海湾合作委员会
    • 南非
    • 中东和非洲其他地区

第十一章 竞争分析

  • 全球市占率分析（2025）
  • 公司简介
    • Illumina公司
    • 赛默飞世尔科技公司
    • F.霍夫曼-拉罗氏有限公司
    • 凯杰
    • 太平洋生物
    • 牛津奈米孔科技公司
    • 珀金埃尔默公司
    • 华大基因
Product Code: FBI101000

Growth Factors of next-generation sequencing (NGS) Market

The global next-generation sequencing (NGS) market was valued at USD 10.44 billion in 2025 and is projected to reach USD 11.79 billion in 2026, eventually growing to USD 38.34 billion by 2034, representing a CAGR of 15.88% during the forecast period. North America dominated the market in 2025 with a 56.01% share, driven by advanced research infrastructure, significant R&D investments, strong adoption of genomics in clinical and research applications, and the presence of leading players like Illumina Inc., Thermo Fisher Scientific Inc., and PacBio.

Next-generation sequencing is a revolutionary technology that enables high-throughput, scalable, and rapid DNA sequencing, transforming genomics research and clinical diagnostics. Its applications span genetic testing, non-invasive prenatal testing, oncology, infectious disease monitoring, and personalized medicine. The COVID-19 pandemic accelerated NGS adoption as the technology was used to study, monitor, and sequence the SARS-CoV-2 virus, boosting research activities and investments in vaccine development.

Key Market Drivers

Diversified Applications in Diagnostics and Research: The decreasing costs of NGS and its high accuracy have expanded its applications in diagnostics, including cancer screening, reproductive health, genetic disorder detection, and companion diagnostics. For example, Thermo Fisher Scientific and Bayer collaborated in March 2024 to develop NGS-based companion diagnostic assays, supporting clinical pipelines.

Technological Advancements and Product Innovation: Continuous innovation in instruments and consumables has enhanced sequencing speed, accuracy, and data analysis. In June 2022, PerkinElmer launched the BioQule NGS System, an automated benchtop solution, while Illumina introduced Connected Insights, a cloud-based software for clinical NGS data analysis in March 2023. These advancements increase accessibility, efficiency, and adoption across research and clinical applications.

Government Initiatives and Genome Projects: Large-scale genome projects, such as the Genome India Project, Personalized Medicine Program (France), and Saudi Human Genome Program, have accelerated NGS adoption. Governments globally are funding genomic research to enhance disease diagnosis, personalized medicine, and biotechnology development.

Market Restraints

The growth of the NGS market faces challenges such as shortage of skilled personnel in developing nations, high investment requirements, and data storage limitations due to the massive volume of sequencing data generated. Additionally, emerging regions may lack sufficient infrastructure to fully leverage NGS technologies, restraining adoption.

Market Segmentation

By Type: The market is segmented into products and services. The products segment dominated the market in 2026 with 86.10% share, including instruments and consumables, due to high usage volume, continuous product launches, and availability. Services, including sequencing as a service, are projected to grow steadily as outsourcing increases.

By Technology: Sequencing technologies include Sequencing by Synthesis (SBS), nanopore sequencing, Ion semiconductor sequencing, and others. SBS held 68.41% share in 2026, led by Illumina's strong product portfolio. Nanopore sequencing is projected to grow rapidly due to portability and long-read capabilities.

By Application: The market is segmented into clinical and research & applied. Clinical applications dominated in 2026 with 51.96% share, driven by oncology, cardiovascular, genetic disorder diagnostics, and reproductive health. Research applications are expected to grow due to large-scale projects and technological adoption.

By End-User: Pharmaceutical & biotechnology companies accounted for 48.00% share in 2026, driven by research collaborations, drug discovery, and NGS adoption in development pipelines. Academic and research institutes are also increasing adoption due to government research funding and genome projects.

Regional Insights

North America generated USD 5.85 billion in 2025 and is projected to reach USD 6.18 billion by 2026, maintaining dominance due to strong research funding and advanced infrastructure. Asia Pacific is expected to witness the highest CAGR, driven by initiatives like the Genome India Project and rapid adoption of genomic medicine in China and Japan. Europe benefits from strong healthcare infrastructure and government support for genomics research. Latin America and the Middle East & Africa are projected to witness moderate growth, supported by partnerships and capacity expansion in genomics.

Competitive Landscape

The NGS market is highly consolidated, led by Illumina Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., QIAGEN, PacBio, Oxford Nanopore Technologies, PerkinElmer, and BGI. Key strategies include product innovation, collaborations, capacity expansion, and strategic partnerships. For instance, Illumina and HaploX collaborated in 2023 to provide locally manufactured sequencing instruments in China.

Conclusion

The global NGS market is projected to experience substantial growth from 2025 to 2034, driven by declining sequencing costs, expanded clinical and research applications, genome projects, technological innovation, and government support. North America remains the largest market, while Asia Pacific is expected to grow at the fastest rate. Dominance in products, SBS technology, clinical applications, and pharmaceutical & biotechnology end-users is expected to continue. Strategic initiatives by major players, along with advancements in sequencing platforms, will drive the market to reach USD 38.34 billion by 2034, enabling improved genomic research, diagnostics, and personalized healthcare worldwide.

Segmentation By Type

  • Products
    • Instruments
    • Consumables
  • Services

By Technology

  • Sequencing By Synthesis (SBS)
  • Nanopore Sequencing
  • ION Semiconductor Sequencing
  • Others

By Application

  • Research & Applied
  • Clinical
    • Cardiovascular
    • Oncology
    • Genetic Diseases
    • Reproductive Health

By End-User

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Others

By Region

  • North America (By Type, Technology, Application, End-User, and Country)
    • U.S.
    • Canada
  • Europe (By Type, Technology, Application, End-User, and Country/ Sub-Region)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Type, Technology, Application, End-User, and Country/ Sub-Region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of the Asia Pacific
  • Latin America (By Type, Technology, Application, End-User, and Country/ Sub-Region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Type, Technology, Application, End-User, and Country/ Sub-Region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Market Scope
  • 1.2. Market Segmentation
  • 1.3. Market Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Key Diseases, By Key Countries, 2025
  • 4.2. Overview: Regulatory Scenario & Reimbursement Scenario, By Key Countries/Region
  • 4.3. New Product Launches, By Key Players
  • 4.4. Key Industry Developments, By Key Players
  • 4.5. Overview: Technological Advancements in Next-generation Sequencing
  • 4.6. Impact of COVID-19 on the Market

5. Global Next-generation Sequencing Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. Products
      • 5.1.1.1. Instruments
      • 5.1.1.2. Consumables
    • 5.1.2. Services
  • 5.2. Market Analysis, Insights and Forecast - By Technology
    • 5.2.1. Sequencing By Synthesis (SBS)
    • 5.2.2. Nanopore Sequencing
    • 5.2.3. ION Semiconductor Sequencing
    • 5.2.4. Others
  • 5.3. Market Analysis, Insights and Forecast - By Application
    • 5.3.1. Research & Applied
    • 5.3.2. Clinical
      • 5.3.2.1. Cardiovascular
      • 5.3.2.2. Oncology
      • 5.3.2.3. Genetic Diseases
      • 5.3.2.4. Reproductive Health
  • 5.4. Market Analysis, Insights and Forecast - By End User
    • 5.4.1. Pharmaceutical & Biotechnology Companies
    • 5.4.2. Academic & Research Institutes
    • 5.4.3. Others
  • 5.5. Market Analysis, Insights and Forecast - By Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa

6. North America Next-generation Sequencing Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. Products
      • 6.1.1.1. Instruments
      • 6.1.1.2. Consumables
    • 6.1.2. Services
  • 6.2. Market Analysis, Insights and Forecast - By Technology
    • 6.2.1. Sequencing By Synthesis (SBS)
    • 6.2.2. Nanopore Sequencing
    • 6.2.3. ION Semiconductor Sequencing
    • 6.2.4. Others
  • 6.3. Market Analysis, Insights and Forecast - By Application
    • 6.3.1. Research & Applied
    • 6.3.2. Clinical
      • 6.3.2.1. Cardiovascular
      • 6.3.2.2. Oncology
      • 6.3.2.3. Genetic Diseases
      • 6.3.2.4. Reproductive Health
  • 6.4. Market Analysis, Insights and Forecast - By End User
    • 6.4.1. Pharmaceutical & Biotechnology Companies
    • 6.4.2. Academic & Research Institutes
    • 6.4.3. Others
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
    • 6.5.2. Canada

7. Europe Next-generation Sequencing Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. Products
      • 7.1.1.1. Instruments
      • 7.1.1.2. Consumables
    • 7.1.2. Services
  • 7.2. Market Analysis, Insights and Forecast - By Technology
    • 7.2.1. Sequencing By Synthesis (SBS)
    • 7.2.2. Nanopore Sequencing
    • 7.2.3. ION Semiconductor Sequencing
    • 7.2.4. Others
  • 7.3. Market Analysis, Insights and Forecast - By Application
    • 7.3.1. Research & Applied
    • 7.3.2. Clinical
      • 7.3.2.1. Cardiovascular
      • 7.3.2.2. Oncology
      • 7.3.2.3. Genetic Diseases
      • 7.3.2.4. Reproductive Health
  • 7.4. Market Analysis, Insights and Forecast - By End User
    • 7.4.1. Pharmaceutical & Biotechnology Companies
    • 7.4.2. Academic & Research Institutes
    • 7.4.3. Others
  • 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.5.1. U.K
    • 7.5.2. Germany
    • 7.5.3. France
    • 7.5.4. Spain
    • 7.5.5. Italy
    • 7.5.6. Scandinavia
    • 7.5.7. Rest of Europe

8. Asia Pacific Next-generation Sequencing Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. Products
      • 8.1.1.1. Instruments
      • 8.1.1.2. Consumables
    • 8.1.2. Services
  • 8.2. Market Analysis, Insights and Forecast - By Technology
    • 8.2.1. Sequencing By Synthesis (SBS)
    • 8.2.2. Nanopore Sequencing
    • 8.2.3. ION Semiconductor Sequencing
    • 8.2.4. Others
  • 8.3. Market Analysis, Insights and Forecast - By Application
    • 8.3.1. Research & Applied
    • 8.3.2. Clinical
      • 8.3.2.1. Cardiovascular
      • 8.3.2.2. Oncology
      • 8.3.2.3. Genetic Diseases
      • 8.3.2.4. Reproductive Health
  • 8.4. Market Analysis, Insights and Forecast - By End User
    • 8.4.1. Pharmaceutical & Biotechnology Companies
    • 8.4.2. Academic & Research Institutes
    • 8.4.3. Others
  • 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.5.1. Japan
    • 8.5.2. China
    • 8.5.3. India
    • 8.5.4. Australia
    • 8.5.5. Southeast Asia
    • 8.5.6. Rest of Asia Pacific

9. Latin America Next-generation Sequencing Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. Products
      • 9.1.1.1. Instruments
      • 9.1.1.2. Consumables
    • 9.1.2. Services
  • 9.2. Market Analysis, Insights and Forecast - By Technology
    • 9.2.1. Sequencing By Synthesis (SBS)
    • 9.2.2. Nanopore Sequencing
    • 9.2.3. ION Semiconductor Sequencing
    • 9.2.4. Others
  • 9.3. Market Analysis, Insights and Forecast - By Application
    • 9.3.1. Research & Applied
    • 9.3.2. Clinical
      • 9.3.2.1. Cardiovascular
      • 9.3.2.2. Oncology
      • 9.3.2.3. Genetic Diseases
      • 9.3.2.4. Reproductive Health
  • 9.4. Market Analysis, Insights and Forecast - By End User
    • 9.4.1. Pharmaceutical & Biotechnology Companies
    • 9.4.2. Academic & Research Institutes
    • 9.4.3. Others
  • 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America

10. Middle East & Africa Next-generation Sequencing Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Type
    • 10.1.1. Products
      • 10.1.1.1. Instruments
      • 10.1.1.2. Consumables
    • 10.1.2. Services
  • 10.2. Market Analysis, Insights and Forecast - By Technology
    • 10.2.1. Sequencing By Synthesis (SBS)
    • 10.2.2. Nanopore Sequencing
    • 10.2.3. ION Semiconductor Sequencing
    • 10.2.4. Others
  • 10.3. Market Analysis, Insights and Forecast - By Application
    • 10.3.1. Research & Applied
    • 10.3.2. Clinical
      • 10.3.2.1. Cardiovascular
      • 10.3.2.2. Oncology
      • 10.3.2.3. Genetic Diseases
      • 10.3.2.4. Reproductive Health
  • 10.4. Market Analysis, Insights and Forecast - By End User
    • 10.4.1. Pharmaceutical & Biotechnology Companies
    • 10.4.2. Academic & Research Institutes
    • 10.4.3. Others
  • 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.5.1. GCC
    • 10.5.2. South Africa
    • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Illumina Inc.
      • 11.2.1.1. Overview
      • 11.2.1.2. Products & services
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Thermo Fisher Scientific Inc.
      • 11.2.2.1. Overview
      • 11.2.2.2. Products & services
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. F. Hoffmann-La Roche Ltd.
      • 11.2.3.1. Overview
      • 11.2.3.2. Products & services
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. QIAGEN
      • 11.2.4.1. Overview
      • 11.2.4.2. Products & services
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. PacBio
      • 11.2.5.1. Overview
      • 11.2.5.2. Products & services
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Oxford Nanopore Technologies
      • 11.2.6.1. Overview
      • 11.2.6.2. Products & services
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Perkin Elmer, Inc.
      • 11.2.7.1. Overview
      • 11.2.7.2. Products & services
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. BGI
      • 11.2.8.1. Overview
      • 11.2.8.2. Products & services
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Next-generation Sequencing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 2: Global Next-generation Sequencing Market Revenue (USD billion) Forecast, by Products, 2021-2034
  • Table 3: Global Next-generation Sequencing Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 4: Global Next-generation Sequencing Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 5: Global Next-generation Sequencing Market Revenue (USD billion) Forecast, by Clinical, 2021-2034
  • Table 6: Global Next-generation Sequencing Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 7: Global Next-generation Sequencing Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 8: North America Next-generation Sequencing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 9: North America Next-generation Sequencing Market Revenue (USD billion) Forecast, by Products, 2021-2034
  • Table 10: North America Next-generation Sequencing Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 11: North America Next-generation Sequencing Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 12: North America Next-generation Sequencing Market Revenue (USD billion) Forecast, by Clinical, 2021-2034
  • Table 13: North America Next-generation Sequencing Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 14: North America Next-generation Sequencing Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 15: Europe Next-generation Sequencing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 16: Europe Next-generation Sequencing Market Revenue (USD billion) Forecast, by Products, 2021-2034
  • Table 17: Europe Next-generation Sequencing Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 18: Europe Next-generation Sequencing Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 19: Europe Next-generation Sequencing Market Revenue (USD billion) Forecast, by Clinical, 2021-2034
  • Table 20: Europe Next-generation Sequencing Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 21: Europe Next-generation Sequencing Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 22: Asia Pacific Next-generation Sequencing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 23: Asia Pacific Next-generation Sequencing Market Revenue (USD billion) Forecast, by Products, 2021-2034
  • Table 24: Asia Pacific Next-generation Sequencing Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 25: Asia Pacific Next-generation Sequencing Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 26: Asia Pacific Next-generation Sequencing Market Revenue (USD billion) Forecast, by Clinical, 2021-2034
  • Table 27: Asia Pacific Next-generation Sequencing Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 28: Asia Pacific Next-generation Sequencing Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 29: Latin America Next-generation Sequencing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 30: Latin America Next-generation Sequencing Market Revenue (USD billion) Forecast, by Products, 2021-2034
  • Table 31: Latin America Next-generation Sequencing Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 32: Latin America Next-generation Sequencing Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 33: Latin America Next-generation Sequencing Market Revenue (USD billion) Forecast, by Clinical, 2021-2034
  • Table 34: Latin America Next-generation Sequencing Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 35: Latin America Next-generation Sequencing Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 36: Middle East & Africa Next-generation Sequencing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 37: Middle East & Africa Next-generation Sequencing Market Revenue (USD billion) Forecast, by Products, 2021-2034
  • Table 38: Middle East & Africa Next-generation Sequencing Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 39: Middle East & Africa Next-generation Sequencing Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 40: Middle East & Africa Next-generation Sequencing Market Revenue (USD billion) Forecast, by Clinical, 2021-2034
  • Table 41: Middle East & Africa Next-generation Sequencing Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 42: Middle East & Africa Next-generation Sequencing Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Next-generation Sequencing Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Next-generation Sequencing Market Value Share (%), by Type, 2025 & 2034
  • Figure 3: Global Next-generation Sequencing Market Value Share (%), by Technology, 2025 & 2034
  • Figure 4: Global Next-generation Sequencing Market Value Share (%), by Application, 2025 & 2034
  • Figure 5: Global Next-generation Sequencing Market Value Share (%), by End User, 2025 & 2034
  • Figure 6: Global Next-generation Sequencing Market Value (USD billion), by Region, 2025 & 2034
  • Figure 7: North America Next-generation Sequencing Market Value (USD billion), by Type, 2025 & 2034
  • Figure 8: North America Next-generation Sequencing Market Value Share (%), by Type, 2025
  • Figure 9: North America Next-generation Sequencing Market Value (USD billion), by Technology, 2025 & 2034
  • Figure 10: North America Next-generation Sequencing Market Value Share (%), by Technology, 2025
  • Figure 11: North America Next-generation Sequencing Market Value (USD billion), by Application, 2025 & 2034
  • Figure 12: North America Next-generation Sequencing Market Value Share (%), by Application, 2025
  • Figure 13: North America Next-generation Sequencing Market Value (USD billion), by End User, 2025 & 2034
  • Figure 14: North America Next-generation Sequencing Market Value Share (%), by End User, 2025
  • Figure 15: North America Next-generation Sequencing Market Value (USD billion), By Country, 2025 & 2034
  • Figure 16: North America Next-generation Sequencing Market Value Share (%), By Country, 2025
  • Figure 17: Europe Next-generation Sequencing Market Value (USD billion), by Type, 2025 & 2034
  • Figure 18: Europe Next-generation Sequencing Market Value Share (%), by Type, 2025
  • Figure 19: Europe Next-generation Sequencing Market Value (USD billion), by Technology, 2025 & 2034
  • Figure 20: Europe Next-generation Sequencing Market Value Share (%), by Technology, 2025
  • Figure 21: Europe Next-generation Sequencing Market Value (USD billion), by Application, 2025 & 2034
  • Figure 22: Europe Next-generation Sequencing Market Value Share (%), by Application, 2025
  • Figure 23: Europe Next-generation Sequencing Market Value (USD billion), by End User, 2025 & 2034
  • Figure 24: Europe Next-generation Sequencing Market Value Share (%), by End User, 2025
  • Figure 25: Europe Next-generation Sequencing Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 26: Europe Next-generation Sequencing Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 27: Asia Pacific Next-generation Sequencing Market Value (USD billion), by Type, 2025 & 2034
  • Figure 28: Asia Pacific Next-generation Sequencing Market Value Share (%), by Type, 2025
  • Figure 29: Asia Pacific Next-generation Sequencing Market Value (USD billion), by Technology, 2025 & 2034
  • Figure 30: Asia Pacific Next-generation Sequencing Market Value Share (%), by Technology, 2025
  • Figure 31: Asia Pacific Next-generation Sequencing Market Value (USD billion), by Application, 2025 & 2034
  • Figure 32: Asia Pacific Next-generation Sequencing Market Value Share (%), by Application, 2025
  • Figure 33: Asia Pacific Next-generation Sequencing Market Value (USD billion), by End User, 2025 & 2034
  • Figure 34: Asia Pacific Next-generation Sequencing Market Value Share (%), by End User, 2025
  • Figure 35: Asia Pacific Next-generation Sequencing Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 36: Asia Pacific Next-generation Sequencing Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 37: Latin America Next-generation Sequencing Market Value (USD billion), by Type, 2025 & 2034
  • Figure 38: Latin America Next-generation Sequencing Market Value Share (%), by Type, 2025
  • Figure 39: Latin America Next-generation Sequencing Market Value (USD billion), by Technology, 2025 & 2034
  • Figure 40: Latin America Next-generation Sequencing Market Value Share (%), by Technology, 2025
  • Figure 41: Latin America Next-generation Sequencing Market Value (USD billion), by Application, 2025 & 2034
  • Figure 42: Latin America Next-generation Sequencing Market Value Share (%), by Application, 2025
  • Figure 43: Latin America Next-generation Sequencing Market Value (USD billion), by End User, 2025 & 2034
  • Figure 44: Latin America Next-generation Sequencing Market Value Share (%), by End User, 2025
  • Figure 45: Latin America Next-generation Sequencing Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 46: Latin America Next-generation Sequencing Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 47: Middle East & Africa Next-generation Sequencing Market Value (USD billion), by Type, 2025 & 2034
  • Figure 48: Middle East & Africa Next-generation Sequencing Market Value Share (%), by Type, 2025
  • Figure 49: Middle East & Africa Next-generation Sequencing Market Value (USD billion), by Technology, 2025 & 2034
  • Figure 50: Middle East & Africa Next-generation Sequencing Market Value Share (%), by Technology, 2025
  • Figure 51: Middle East & Africa Next-generation Sequencing Market Value (USD billion), by Application, 2025 & 2034
  • Figure 52: Middle East & Africa Next-generation Sequencing Market Value Share (%), by Application, 2025
  • Figure 53: Middle East & Africa Next-generation Sequencing Market Value (USD billion), by End User, 2025 & 2034
  • Figure 54: Middle East & Africa Next-generation Sequencing Market Value Share (%), by End User, 2025
  • Figure 55: Middle East & Africa Next-generation Sequencing Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 56: Middle East & Africa Next-generation Sequencing Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 57: Global Next-generation Sequencing Market Share (%), By Company, 2025